Skip to main content
. 2022 May 9;29:29. doi: 10.1186/s12929-022-00812-3

Fig. 4.

Fig. 4

Effects of myricetin and enzalutamide alone and in combination. C4-2B cells were treated with indicated concentrations of the drugs (M, myricetin; Enza, enzalutamide; M + Enza: the combination of myricetin and enzalutamide). The ratio of Myricetin/enzalutamide is [IC50]Myricetin/[IC50]enzalutamide based on the Chou-Talalay method [39]. Cell viability was measured using the MTT assay, the non-linear regression trendline analysis of IC50 values was calculated by Prism7 and the CI values were generated by CompuSyn